BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17264784)

  • 1. Is it time to ditch 131I ablation?
    Buscombe JR; Taher MA
    Nucl Med Commun; 2007 Mar; 28(3):231; author reply 231-2. PubMed ID: 17264784
    [No Abstract]   [Full Text] [Related]  

  • 2. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
    Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
    Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities and limits of radiologic treatment of malignant struma].
    zur Horst-Meyer H; Correns HJ
    Z Arztl Fortbild (Jena); 1982 Jan; 76(1-2):15-7. PubMed ID: 7080514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differentiated thyroid carcinomas. Radical therapeutic strategy].
    Berchtold R; Rösler H; Büll U; Leisner B; Emrich D; Becker HD; Droese M; Pichlmaier H; Reinwein D; Röher HD
    Dtsch Med Wochenschr; 1984 Apr; 109(16):626-34. PubMed ID: 6714092
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 7. Papillary thyroid carcinoma in a 3-year-old child: case report.
    Alkan S; Seven H; Sakalli E; Dadaş B
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):275-7. PubMed ID: 18061281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiated thyroid cancers].
    Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
    G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-active iodine in the treatment of cancer of the thyroid.
    Lahneche B
    Ann Radiol (Paris); 1977; 20(8):779-82. PubMed ID: 610549
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcome after 131I therapy.
    Sioka C; Fotopoulos A
    J Nucl Med; 2009 Feb; 50(2):327; author reply 327-8. PubMed ID: 19164224
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid cancer guidelines--what's new?
    Gerrard G; Gill V
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):264-6. PubMed ID: 18343311
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma.
    Roh JL; Park CI
    Cancer; 2008 Oct; 113(7):1527-31. PubMed ID: 18671238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.
    Zanotti-Fregonara P; Hindié E; Faugeron I; Moretti JL; Ravasi L; Rubello D; Toubert ME
    Minerva Endocrinol; 2008 Dec; 33(4):313-27. PubMed ID: 18923368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
    Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer in infants and adolescents after Chernobyl.
    Reiners C; Demidchik YE; Drozd VM; Biko J
    Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of induced accumulative ability in differentiated carcinoma of the thyroid gland for the prognosis of the disease].
    Nĕmec J; Zamrazil V; Pohunková D; Röhling S; Neradilová M; Heserová J
    Cesk Radiol; 1986 May; 40(3):184-9. PubMed ID: 3719849
    [No Abstract]   [Full Text] [Related]  

  • 20. ¹³¹I sodium-iodide versus ⁵⁶Fe surgical steel. Which is better for lateral lymph node metastases in differentiated thyroid cancer patients?
    Verburg F; Weber T; Luster M
    Nuklearmedizin; 2013; 52(4):113-4. PubMed ID: 23928980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.